Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1975 Feb;1(2):201–205. doi: 10.1128/jcm.1.2.201-205.1975

Large-scale production of rubella precipitinogens and their use in the diagnostic laboratory.

R Cappel, A Schluederberg, D M Horstmann
PMCID: PMC275019  PMID: 809471

Abstract

A method for producing large quantities of rubella theta and iota precipitating antigens in Vero cells is described. Using this reagent, the detection of anti-theta antibodies was found to be as sensitive as the hemagglutination inhibition test for both the determination of immune status and the diagnosis of acute rubella infection. The detection of anti-iota antibodies may permit diagnosis of rubella infection, when the collection of the first serum has been delayed and the early rise of hemagglutin-inhibiting and anti-theta antibodies has been missed.

Full text

PDF
201

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cappel R., Schluederberg A., Gifford R. H., Horstmann D. M. Characterization of a human acute phase protein found in association with rubella virus infection. J Exp Med. 1974 Mar 1;139(3):497–511. doi: 10.1084/jem.139.3.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Horstmann D. M., Liebhaber H., Le Bouvier G. L., Rosenberg D. A., Halstead S. B. Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic. N Engl J Med. 1970 Oct 8;283(15):771–778. doi: 10.1056/NEJM197010082831501. [DOI] [PubMed] [Google Scholar]
  3. LE BOUVIER G. L. Poliovirus precipitins; a study by means of diffusion in agar. J Exp Med. 1957 Nov 1;106(5):661–676. doi: 10.1084/jem.106.5.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Le Bouvier G. L. Physicochemical characteristics of rubella antigens theta and iota. Nature. 1969 Jan 4;221(5175):78–79. doi: 10.1038/221078a0. [DOI] [PubMed] [Google Scholar]
  5. Le Bouvier G. L., Plotkin S. A. Precipitin responses to rubella vaccine RA 27-3. J Infect Dis. 1971 Feb;123(2):220–223. doi: 10.1093/infdis/123.2.220. [DOI] [PubMed] [Google Scholar]
  6. Le Bouvier G. L. Precipitinogens of rubella virus-infected cells. Proc Soc Exp Biol Med. 1969 Jan;130(1):51–54. doi: 10.3181/00379727-130-33486. [DOI] [PubMed] [Google Scholar]
  7. Liebhaber H., Gross P. A. The structural proteins of rubella virus. Virology. 1972 Mar;47(3):684–693. doi: 10.1016/0042-6822(72)90558-2. [DOI] [PubMed] [Google Scholar]
  8. Liebhaber H. Measurement of rubella antibody by hemagglutination inhibition. II. Characteristics of an improved HAI test employing a new method for the removal of non-immunoglobulin HA inhibitors from serum. J Immunol. 1970 Apr;104(4):826–834. [PubMed] [Google Scholar]
  9. Liebhaber H., Pajot T., Riordan J. T. Growth of high titered rubella virus in roller bottle cultures of Vero cells. Proc Soc Exp Biol Med. 1969 Jan;130(1):12–14. doi: 10.3181/00379727-130-33477. [DOI] [PubMed] [Google Scholar]
  10. McCollum R. W., Randolph M. F., Byrne E. B., Hilleman M. R. Rubella virus vaccine (HPV-77-DE 5). Antigenic and protective efficacy in a community trial. Am J Dis Child. 1969 Aug;118(2):186–189. doi: 10.1001/archpedi.1969.02100040188005. [DOI] [PubMed] [Google Scholar]
  11. PARKMAN P. D., BUESCHER E. L., ARTENSTEIN M. S. Recovery of rubella virus from army recruits. Proc Soc Exp Biol Med. 1962 Oct;111:225–230. doi: 10.3181/00379727-111-27750. [DOI] [PubMed] [Google Scholar]
  12. Salmi A. A. Gel precipitation reactions between alkaline extracted rubella antigens and human sera. Acta Pathol Microbiol Scand. 1969;76(2):271–278. doi: 10.1111/j.1699-0463.1969.tb03257.x. [DOI] [PubMed] [Google Scholar]
  13. Schmidt N. J., Styk B. Immunodiffusion reactions with rubella antigens. J Immunol. 1968 Aug;101(2):210–216. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES